NASDAQ:PRFX - Nasdaq - IL0011651580 - Common Stock - Currency: USD
3.16
-0.32 (-9.2%)
The current stock price of PRFX is 3.16 USD. In the past month the price decreased by -0.94%. In the past year, price decreased by -93.07%.
Symbol | Name | TA | FA | PE | Market Cap |
---|---|---|---|---|---|
LLY | ELI LILLY & CO | 67.21 | 829.40B | ||
NVO | NOVO-NORDISK A/S-SPONS ADR | 27.53 | 390.99B | ||
JNJ | JOHNSON & JOHNSON | 16.25 | 390.76B | ||
AZN | ASTRAZENECA PLC-SPONS ADR | 20.56 | 230.17B | ||
MRK | MERCK & CO. INC. | 11.71 | 226.40B | ||
NVS | NOVARTIS AG-SPONSORED ADR | 13.77 | 215.98B | ||
PFE | PFIZER INC | 8.46 | 149.04B | ||
SNY | SANOFI-ADR | 13.62 | 136.54B | ||
BMY | BRISTOL-MYERS SQUIBB CO | 48.97 | 113.23B | ||
GSK | GSK PLC-SPON ADR | 7.81 | 74.77B | ||
ZTS | ZOETIS INC | 27.1 | 72.39B | ||
TAK | TAKEDA PHARMACEUTIC-SP ADR | 31.95 | 44.58B |
PainReform Ltd. is a pharmaceutical company, which focuses on reformulation of established therapeutics. The Company’s main activity is to develop reformulation of established pain therapeutics. PainReform Ltd provides technology, which is dedicated to prolong and enhance efficacy, minimize adverse effects and increase patients convenience as well as faster return of motor function.
PAINREFORM LTD
65 Yigal Alon St.
TEL AVIV-YAFO 6745442 IL
CEO: Ilan Hadar
Employees: 7
Company Website: https://painreform.com/
Investor Relations: http://painreform.com/investors
Phone: 97237177051
The current stock price of PRFX is 3.16 USD. The price decreased by -9.2% in the last trading session.
The exchange symbol of PAINREFORM LTD is PRFX and it is listed on the Nasdaq exchange.
PRFX stock is listed on the Nasdaq exchange.
PAINREFORM LTD (PRFX) has a market capitalization of 2.75M USD. This makes PRFX a Nano Cap stock.
PAINREFORM LTD (PRFX) currently has 7 employees.
PAINREFORM LTD (PRFX) has a support level at 2.89 and a resistance level at 3.58. Check the full technical report for a detailed analysis of PRFX support and resistance levels.
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
PRFX does not pay a dividend.
PAINREFORM LTD (PRFX) will report earnings on 2025-02-27, after the market close.
PAINREFORM LTD (PRFX) does not have a PE ratio as the earnings reported over the last twelve months were negative (-179.76).
The outstanding short interest for PAINREFORM LTD (PRFX) is 7.62% of its float. Check the ownership tab for more information on the PRFX short interest.
ChartMill assigns a technical rating of 1 / 10 to PRFX. When comparing the yearly performance of all stocks, PRFX is a bad performer in the overall market: 94.48% of all stocks are doing better.
ChartMill assigns a fundamental rating of 1 / 10 to PRFX. Both the profitability and financial health of PRFX have multiple concerns.
Over the last trailing twelve months PRFX reported a non-GAAP Earnings per Share(EPS) of -179.76. The EPS decreased by -1758.81% compared to the year before.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | N/A | ||
ROA | -568.81% | ||
ROE | N/A | ||
Debt/Equity | N/A |
ChartMill assigns a Buy % Consensus number of 43% to PRFX. The Buy consensus is the average rating of analysts ratings from 6 analysts.